Tamás Ágh MD MSc PhD DrHabil graduated from the Semmelweis Medical University (MD, 2006), the Corvinus University of Budapest (MSc Physician-Economist, 2010), the Semmelweis University School of PhD Studies (PhD in Pharmacoeconomics, 2013) and the University of Pecs Doctoral School of Health Sciences (DrHabil in Health Sciences, 2020). He specialized in family medicine in 2010. Dr. Ágh is a research associate professor at the Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pecs, a principal researcher of Syreon Research Institute and has been practicing as a medical doctor since 2006. From 2011 to 2013 he worked in licensing and global business development in the pharmaceutical industry. With 15 years of experience in health economics and outcome research, he developed expertise in the fields of PROs (i.e., medication adherence, quality of life), health technology assessment, and evidence synthesis. Dr. Ágh is a member of the leadership group of the ISPOR Medication Adherence and Persistence Special Interest Group and the European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE) Cost Action.